https://www.news-medical.net/news/2008/11/24/43340.aspx
Medarex starts phase 1b clinical trial with MDX-1106 for the treatment of cancer
Nov 25, 2008 - Medarex, Inc. has announced it has initiated a Phase 1b clinical trial for MDX-1106 (ONO-4538: development code of Ono Pharmaceutical Co., Ltd.), a fully human...
https://www.biospace.com/medarex-inc-and-b-genpat77-b-announce-therapeutic-antibody-co-development-agreement
Medarex, Inc. And GenPat77 Announce Therapeutic Antibody Co-Development Agreement - BioSpace
therapeutic antibodyco developmentmedarexincannounce
https://www.biospace.com/ono-pharmaceutical-company-ltd-and-medarex-inc-enter-into-second-collaboration-for-the-development-of-a-fully-human-antibody-therapeutic
Ono Pharmaceutical Company, Ltd. And Medarex, Inc. Enter Into Second Collaboration For The...
https://www.biospace.com/medarex-inc-and-massachusetts-biologic-laboratories-announce-commencement-of-phase-ii-clinical-trial-of-anti-c-difficile-antibody-combination-for-t
Medarex, Inc. And Massachusetts Biologic Laboratories Announce Commencement Of Phase II Clinical...